Concepedia

Hector U. Lopez

HU

4

Publications

968

Citations

4

H-Index

2011

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Agios Pharmaceuticals (United States)

Hector U. Lopez is an author at Harvard University specializing in tumor biology, orthopaedics, and oncology.

Top concepts

Publications per year

2011–2014

4

Publications

4

Frequent Mutation of Isocitrate Dehydrogenase<i>(IDH)1</i>and<i>IDH2</i>in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

Darrell R. Borger, Kenneth K. Tanabe, Kenneth C. Fan et al. · The Oncologist · 2011 · 702 citations · Full text

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Amir Fathi, Hossein Sadrzadeh, Darrell R. Borger et al. · Blood · 2012 · 122 citations · Full text

Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations

Darcy A. Kerr, Hector U. Lopez, Vikram Deshpande et al. · The American Journal of Surgical Pathology · 2013 · 103 citations

, , +13

Dual HER2 Targeting Impedes Growth of <i>HER2</i> Gene–Amplified Uterine Serous Carcinoma Xenografts

Jolijn W. Groeneweg, Sílvia Hernández, Virginia F. Byron et al. · Clinical Cancer Research · 2014 · 41 citations · Full text

Rows per page

1–4 of 4